Chia SKL - Search Results

1

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Chia SKL, Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Kim SB, Jakobsen EH, Harvey V, Robert N, Smith J 2nd, Harker G, Zhang B, Eli LD, Ye Y, Lalani AS, Buyse M, Chan A. Chia SKL, et al. Breast Cancer Res. 2019 Mar 11;21(1):39. doi: 10.1186/s13058-019-1115-2. Breast Cancer Res. 2019. PMID: 30867034 Free PMC article. Clinical Trial.

2

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer.

Chia SK, Speers CH, D'yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'reilly SE, Olivotto IA. Chia SK, et al. Cancer. 2007 Sep 1;110(5):973-9. doi: 10.1002/cncr.22867. Cancer. 2007. PMID: 17647245 Free article.

3

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.

Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA. Kennecke H, et al. Cancer. 2008 Apr 1;112(7):1437-44. doi: 10.1002/cncr.23320. Cancer. 2008. PMID: 18286526 Free article.

4

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Cheang MC, et al. Clin Cancer Res. 2008 Mar 1;14(5):1368-76. doi: 10.1158/1078-0432.CCR-07-1658. Clin Cancer Res. 2008. PMID: 18316557

5

Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.

Chia S, Gradishar W, Mauriac L, Bines J, Amant F, Federico M, Fein L, Romieu G, Buzdar A, Robertson JF, Brufsky A, Possinger K, Rennie P, Sapunar F, Lowe E, Piccart M. Chia S, et al. J Clin Oncol. 2008 Apr 1;26(10):1664-70. doi: 10.1200/JCO.2007.13.5822. Epub 2008 Mar 3. J Clin Oncol. 2008. PMID: 18316794 Clinical Trial.

6

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

Crabb SJ, Cheang MC, Leung S, Immonen T, Nielsen TO, Huntsman DD, Bajdik CD, Chia SK. Crabb SJ, et al. Clin Breast Cancer. 2008 Jun;8(3):249-56. doi: 10.3816/CBC.2008.n.028. Clin Breast Cancer. 2008. PMID: 18650155

7

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.

Liu S, Chia SK, Mehl E, Leung S, Rajput A, Cheang MC, Nielsen TO. Liu S, et al. Breast Cancer Res Treat. 2010 Jan;119(1):53-61. doi: 10.1007/s10549-009-0318-0. Epub 2009 Feb 10. Breast Cancer Res Treat. 2010. PMID: 19205877

8

A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers.

Yerushalmi R, Hayes MM, Gelmon KA, Chia S, Bajdik C, Norris B, Speers C, Hassell P, O'Reilly SE, Allan S, Shenkier TN. Yerushalmi R, et al. Clin Breast Cancer. 2009 Aug;9(3):166-72. doi: 10.3816/CBC.2009.n.027. Clin Breast Cancer. 2009. PMID: 19661040 Clinical Trial.

9

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, Clarke B, Sutherland BW, Waterhouse D, Bally M, Roskelley C, Overall CM, Minchinton A, Pacchiano F, Carta F, Scozzafava A, Touisni N, Winum JY, Supuran CT, Dedhar S. Lou Y, et al. Cancer Res. 2011 May 1;71(9):3364-76. doi: 10.1158/0008-5472.CAN-10-4261. Epub 2011 Mar 17. Cancer Res. 2011. PMID: 21415165

10

Trends in improving survival in breast cancer: two steps forward but one step back?

Chia S. Chia S. Breast Cancer Res Treat. 2011 Aug;128(3):807-9. doi: 10.1007/s10549-011-1490-6. Epub 2011 Apr 12. Breast Cancer Res Treat. 2011. PMID: 21484290 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters